γ-tocotrienol controls proliferation, modulates expression of cell cycle regulatory proteins and up-regulates quinone reductase NQO2 in MCF-7 breast cancer cells

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 2869-2874

  Hsieh, Tze Chen ^a   Elangovan, Selvakumar ^a   Wu, Joseph M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

tocotrienol; Breast cancer; Cell cycle; Cyclin D1; MCF 7 cells; Quinone reductase NQO2; Retinoblastoma

Indexed keywords

CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 4; ESTROGEN RECEPTOR; GAMMA TOCOTRIENOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE) 2; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DETOXIFICATION; DOSE RESPONSE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; TIME; UPREGULATION;

BREAST NEOPLASMS; CELL CYCLE; CELL CYCLE PROTEINS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CHROMANS; ENZYME INDUCTION; GENE EXPRESSION; HUMANS; QUINONE REDUCTASES; UP-REGULATION; VITAMIN E;

EID: 77955787273     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
2. Rock CL and Demark-Wahnefried W: Can lifestyle modification increase survival in women diagnosed with breast cancer? J Nutr 132: 3504S-3507S, 2002.
3. Rock E and DeMichele A: Nutritional approaches to late toxicities of adjuvant chemotherapy in breast cancer survivors. J Nutr 133: 3785S-3793S, 2003. (Pubitemid 37392601)
4. McIntyre BS, Briski KP, Gapor A and Sylvester PW: Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med 224: 292-301, 2000. (Pubitemid 30643508)
5. McIntyre BS, Briski KP, Tirmenstein MA, Fariss MW, Gapor A and Sylvester PW: Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells. Lipids 35: 171-180, 2000. (Pubitemid 30183648)
6. You H, Yu W, Sanders BG and Kline K: RRR-alpha-tocopheryl succinate induces MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation. Cell Growth Differ 12: 471-480, 2001. (Pubitemid 32906092)
7. Nesaretnam K: Multitargeted therapy of cancer by tocotrienols. Cancer Lett 269: 388-395, 2008.
8. Guthrie N, Gapor A, Chambers AF and Carroll KK: Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. J Nutr 127: 544S-548S, 1997. (Pubitemid 27120013)
9. Sen CK, Khanna S and Roy S: Tocotrienols: Vitamin E beyond tocopherols. Life Sci 78: 2088-2098, 2006.
10. Nesaretnam K, Stephen R, Dils R and Darbre P: Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33: 461-469, 1998. (Pubitemid 28261949)
11. Yu W, Simmons-Menchaca M, Gapor A, Sanders BG and Kline K: Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr Cancer 33: 26-32, 1999. (Pubitemid 29196119)
12. Shun MC, Yu W, Gapor A, Parsons R, Atkinson J, Sanders BG and Kline K: Pro-apoptotic mechanisms of action of a novel vitamin E analog (alpha-TEA) and a naturally occurring form of vitamin E (delta-tocotrienol) in MDA-MB-435 human breast cancer cells. Nutr Cancer 48: 95-105, 2004. (Pubitemid 38823551)
13. Kong AN, Yu R, Hebbar V, Chen C, Owuor E, Hu R, Ee R and Mandlekar S: Signal transduction events elicited by cancer prevention compounds. Mutat Res 480-481: 231-241, 2001.
14. Gaikwad NW, Yang L, Rogan EG and Cavalieri EL: Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones. Free Radic Biol Med 46: 253-262, 2009.
15. Hsieh TC, Wijeratne EK, Liang JY, Gunatilaka AL and Wu JM: Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the Chinese herb Rabdosia rubescens. Biochem Biophys Res Commun 337: 224-231, 2005.
16. Yu KD, Di GH, Yuan WT, Fan L, Wu J, Hu Z, Shen ZZ, Zheng Y, Huang W and Shao ZM: Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53. Hum Mol Genet 18: 2502-2517, 2009.
17. Elangovan S, Hsieh TC and Wu JM: Growth inhibition of human MDA-mB-231 breast cancer cells by delta-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product. Anticancer Res 28: 2641-2647, 2008.